Dacco V, Rosazza C, Mariani A, Rizza C, et al. Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor treatment in children aged 6-11 years with cystic fibrosis in a real-world setting. Pediatr Pulmonol 2024;59:2792-2799.
PMID: 38869349